2024 HFSA CME Symposium - Mastering the Dynamics of Worsening HFrEF: An In-Depth Approach to Effective Management

By: PRLog

August 09, 2024 at 20:00 PM EDT

This CME Symposium takes place on Saturday, September 28, 2024 from 7:15 - 8:45 PM ET during the 2024 Heart Failure Society of America (HFSA) Annual Scientific Meeting at the Signia by Hilton Atlanta in Atlanta, Georgia in the Triumph Ballroom G.

HAZLET, N.J. - Aug. 9, 2024 - PRLog -- In this educational initiative, to take place at the 2024 Heart Failure Society of America (HFSA) Annual Scientific Meeting, experts in WHF will provide attendees with the current definition for WHF; describe its association with poor clinical outcomes; and emphasize the need for prevention of WHF, early diagnosis, and urgent escalation of treatment. Effective treatment strategies will be described, including the evidence for and utilization of additional medical therapies for worsening HFrEF on top of quadruple therapy. A case discussion will illustrate best practices for multidisciplinary care.

The educational objectives include:

Explain the current definition of worsening heart failure (WHF) and its life-threatening consequences Identify strategies to facilitate a rapid, accurate diagnosis of WHF
Discuss the evidence illustrating deficiencies in optimizing guideline directed medical therapy (GDMT) in individuals with worsening heart failure with reduced ejection fraction (HFrEF)
Describe the efficacy and safety of additional therapies used to manage patients with worsening HFrEF
Recognize the integral roles of multidisciplinary clinicians in managing patients with worsening HFrEF

Click here for more information

CHAIR
Javed Butler, MD, MPH, MBA
President, Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi

FACULTY
Marie Galvao, MSN, ANP-BC, CHF-N, HF-Cert
Lead Heart Failure Nurse Practitioner
Montefiore Medical Center
Bronx, New York

Stephen J. Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

Orly Vardeny, PharmD
Associate Professor of Medicine
University of Minnesota Medical School
Minneapolis, Minnesota

This educational activity is intended for clinicians who manage patients with heart failure.

This activity is supported by an educational grant from Merck & Co., Inc.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1.5 Credits™ through its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Contact
Voxmedia
***@voxmedia.us
Photos: (Click photo to enlarge)